Sign in
BNOX Stock Price, Chart, Stats & News
Bionomics Limited
Save
4.95M
Market cap
–
Current P/E
–
Forward P/E
BNOX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 100.00% |
Operating margin | 170741.95% |
Pretax margin | 127240.41% |
Net margin | 56574.31% |
Effective tax rate | 55.53% |
ROA | -1024.44% |
ROE | -7.86% |
D/E | – |
Interest coverage ratio | – |
BNOX valuation
P/E | – |
P/S | -7.48x |
P/B | 0.00x |
P/CF | 0.00x |
P/FCF | 0.07x |
P/OCF | 0.00x |
PEG | -0.00x |
EV multiple | -0.03x |
About
Bionomics Limited is an Australian biopharmaceutical company operating at the clinical stage, dedicated to the discovery and advancement of innovative therapeutic compounds. Its research efforts primarily target central nervous system disorders and various cancers, with operations spanning Australia and the United States. A key experimental medicine in its portfolio is BNC210.
Similar securities
Based on sector and market capitalization
Report issue